Navigation Links
IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Date:8/27/2007

IRVINE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- IDM Pharma (Nasdaq: IDMI) today announced that Jeffrey W. Sherman, M.D., F.A.C.P. has been appointed as the Company's Chief Medical Officer and Senior Vice President of Research and Development. Dr. Sherman will join the Company in September and will report to President and CEO Timothy P. Walbert.

Dr. Sherman brings close to 20 years of pharmaceutical experience to IDM Pharma and will lead the regulatory and clinical strategy for L-MTP-PE and the development of the Company's pipeline, including UVIDEM and IDM-2101. He joins IDM Pharma from Takeda Global Research & Development Center, Inc., a subsidiary of Takeda Pharmaceutical Company Limited, where he served as Vice President of Clinical Science and was focused on developing Takeda's oncology pipeline.

"Dr. Sherman's depth of oncology experience and pharmaceutical and biotechnology expertise will be an asset as we continue to work through the regulatory process with L-MTP-PE and develop our oncology pipeline," said Timothy P. Walbert, President and Chief Executive Officer of IDM Pharma, Inc. "In the near-term, Dr. Sherman will oversee the preparation and submission of the L-MTP-PE NDA amendment in the US and work closely with regulatory authorities in Europe to complete the L-MTP-PE review process."

About Dr. Jeffrey Sherman

Dr. Sherman joins IDM Pharma from Takeda Global Research & Development Center, Inc., a subsidiary of Takeda Pharmaceutical Company Limited, where he served as Vice President of Clinical Science, Oncology. Prior to Takeda, Dr. Sherman served as Chief Medical Officer and Executive Vice President at NeoPharm, Inc. where he was responsible for developing clinical drug research and development strategies.

Before joining NeoPharm, Dr. Sherman held various roles at Searle/Pharmacia Research and Development, and Medical Marketing, including Executive Director of Clinical Research and Head of Oncology Medical Operatio
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma...attheNASDAQOMXconferenceonTuesday,December1stat1:4...stenvialiveaudiobroadcastovertheInternetavailablea....Userscanclickthe"Webcast"icontoaccessthisfile. ,...LifeScienceandHighTechnologycompany.Itschemicaland...
(Date:11/24/2009)...,, SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/...companyfocusedondevelopingandcommercializingnovelp...Tonno,PresidentandChiefExecutiveOfficer,isschedule...ference,tobeheldDecember1-2,2009atTheNewYorkPalace...Ghiglieri,ChiefFinancialOfficer,willbeavailabletor...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatients...,, QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEte..."),aglobalbiopharmaceuticalcompanyfocusedonendocri...ydatafromaPhase2studywithitstargetedcytotoxicpepti...hadvancedorrecurrentendometrialcancer.Inapersonali...
(Date:11/24/2009)...,, REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCa...edthatRandyScott,GenomicHealth,sExecutiveChairman,...nferenceinNewYorkCityonTuesday,December1,2009at10:...ivedwebcastofthepresentation,visittheInvestorRelat...tor.genomichealth.com .Pleaseconnecttothewebsiteat...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...hone calls over the Internet are no longer a pipe ... s May 20 presentation, a panel discussion of Voic...y to carry phone conversations over existing data ...y. Speaker Jerry Rocco, an IP telephony specialist...h his phone is connected not to a phone jack but t...
...concept in business today is performance-based man... management vernacular such as customer-centric, v... of implied and sometimes contradictory meanings. ...niques fall in the category of what I call managem...whacking people upside the head to get them to do ...
...For children growing up poor, money isn,t the only... , ,According to a new study, the genes and warm s... children against many of the cognitive and behavi... The findings are published in the May issue of th...how that economic hardship during childhood elevat...
Other Biology Technology:VoIP experts assess early implementations 2VoIP experts assess early implementations 3The myth of the performance-based management 2The myth of the performance-based management 3Study shows that genes can protect kids against poverty 2Study shows that genes can protect kids against poverty 3
(Date:11/23/2009)...ity of Alabama at Birmingham (UAB) researchers sho...cal conditions (co-morbidity) do not explain the d... compared to Caucasians who also have colon cancer... , a journal of the American Cancer Society. , T...idity are independent predictors of poor survival ...
(Date:11/23/2009)...nprecedented detail how the ribosome interacts wit...de them toward their destination in biological cel...itting (MDFF) to examine the interaction of the ri... The first study, in Proceedings of the National ...ing between the ribosome and an elongation factor ...
(Date:11/23/2009)...ies about the multiple health benefits of vitamin ...ent, increased awareness of the huge numbers of pe... even led to an appreciation of it as "nature,s an...f your immune system to prevention of heart diseas...s now seen as one of the most critical nutrients f...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3Video 3A Bon Secours Finds Young Families are In Line With National Economic Trend 47944 1Video 3A Bon Secours Finds Young Families are In Line With National Economic Trend 47944 2Video 3A Bon Secours Finds Young Families are In Line With National Economic Trend 47944 3Neudesic Works With Microsoft to Provide HIPAA 4010 5010 Support for BizTalk Server 47940 1Neudesic Works With Microsoft to Provide HIPAA 4010 5010 Support for BizTalk Server 47940 2Penn study demonstrates new way to boost immune memory 47936 1Penn study demonstrates new way to boost immune memory 47936 2Penn study demonstrates new way to boost immune memory 47936 3
... feelings into words — talking with a therapist or...tter" A new brain imaging study by UCLA psychologi... sadness, anger and pain less intense. , Another ... same members of the research team, combines moder...provide the first neural evidence for why “mindful...
... the genetics behind why C. difficile causes disea...ia do it because they are starving. That just migh...times be a very difficult disease to treat. , "The...to be expressed during periods of nutrient depriva... disease-causing bacteria express their pathogenic...
...covery that someday may help cure type 1 diabetes ...ucing cells for a damaged or defective pancreas, m...ve engineered adult stem cells derived from human ...earchers announced their laboratory finding, which...007 issue of the medical journal Cell Proliferatio...
Other Biology News:Putting feelings into words produces therapeutic effects in the brain 2Putting feelings into words produces therapeutic effects in the brain 3Putting feelings into words produces therapeutic effects in the brain 4Putting feelings into words produces therapeutic effects in the brain 5Understanding why C. difficile causes disease -- it's hungry 2Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin 2Adult stem cells from human cord umbilical cord blood successfully engineered to make insulin 3
Goat Anti-Human AHI1 / Jouberin Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human CD182 (CXCR2) Monoclonal Antibody, Unconjugated, Clone 5E8/CXCR2 from BioLegend
Rabbit Anti-eIF-4E (Poly6069) Polyclonal Antibody, Unconjugated from BioLegend
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: